Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24353 | 263 | 40.6 | 92% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1187 | 8873 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CTHRC1 | Author keyword | 7 | 64% | 3% | 7 |
| 2 | COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 | Author keyword | 3 | 100% | 1% | 3 |
| 3 | CAROTID ARTERY RESTENOSIS | Author keyword | 2 | 67% | 1% | 2 |
| 4 | ZNF580 | Author keyword | 1 | 40% | 1% | 2 |
| 5 | VASC GENE THER Y UNIT | Address | 1 | 33% | 1% | 2 |
| 6 | ADAPTIVE REMODELLING | Author keyword | 1 | 50% | 0% | 1 |
| 7 | ANTI TRANSFORMING GROWTH FACTOR BETA | Author keyword | 1 | 50% | 0% | 1 |
| 8 | BALLOON ANGIOPLASTY AND STENTING | Author keyword | 1 | 50% | 0% | 1 |
| 9 | BIOMED UNIT FDN | Address | 1 | 50% | 0% | 1 |
| 10 | CLIN FORUM | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRIPLE HELIX REPEAT | 9 | 48% | 5% | 13 |
| 2 | CTHRC1 | 8 | 75% | 2% | 6 |
| 3 | LUMINAL LOSS | 6 | 71% | 2% | 5 |
| 4 | LIPID LESIONS | 3 | 45% | 2% | 5 |
| 5 | ACCELERATES ATHEROSCLEROSIS | 3 | 12% | 8% | 22 |
| 6 | TRANSGENIC APOLIPOPROTEINA MICE | 2 | 36% | 2% | 5 |
| 7 | HUMAN VASCULAR RESTENOSIS | 2 | 43% | 1% | 3 |
| 8 | ACTIVIN A EXPRESSION | 1 | 50% | 0% | 1 |
| 9 | ANGIOPLASTY INJURY | 1 | 50% | 0% | 1 |
| 10 | DENUDATION INJURY | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| TGF-beta and Restenosis Revisited: A Smad Link | 2011 | 20 | 99 | 28% |
| Transforming growth factor beta and atherosclerosis: So far, so good for the protective cytokine hypothesis | 2004 | 154 | 43 | 33% |
| Transforming growth factor-beta and atherosclerosis: interwoven atherogenic and atheroprotective aspects | 2012 | 25 | 189 | 21% |
| TGF-beta and atherosclerosis in man | 2007 | 69 | 90 | 31% |
| Transforming growth factor-beta s and vascular disorders | 2006 | 136 | 98 | 14% |
| TGF-beta signaling in vascular fibrosis | 2007 | 206 | 72 | 11% |
| The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor, beta signaling | 2007 | 22 | 15 | 47% |
| Understanding the role of transfonning growth factor-beta 1 in intimal thickening after vascular injury | 2007 | 51 | 111 | 25% |
| The role of Smad3-dependent TGF-beta signal in vascular response to injury | 2006 | 10 | 39 | 46% |
| The role of transforming growth factor-beta in atherosclerosis | 2006 | 43 | 166 | 22% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VASC GENE THER Y UNIT | 1 | 33% | 0.8% | 2 |
| 2 | BIOMED UNIT FDN | 1 | 50% | 0.4% | 1 |
| 3 | CLIN FORUM | 1 | 50% | 0.4% | 1 |
| 4 | DIPATIMENTO BIOPATOL METODOL BIOMED | 1 | 50% | 0.4% | 1 |
| 5 | EPITHELIAL DAMAGE REPAIR TISSUE ENGN | 1 | 50% | 0.4% | 1 |
| 6 | ERI AG S VASC REPONSES TISSULAI 22 | 1 | 50% | 0.4% | 1 |
| 7 | EXPT MED SERV | 1 | 50% | 0.4% | 1 |
| 8 | MINIST EDUC MINIMALLY INVAS GASTROINTESTINAL | 1 | 50% | 0.4% | 1 |
| 9 | SECT MEDCARDIOVASC GRP | 1 | 50% | 0.4% | 1 |
| 10 | SERV GEN ABDOMINAL SURG | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000241158 | CELLULAR REPRESSOR OF E1A STIMULATED GENES//CREG//CELLULAR REPRESSOR OF E1A STIMULATED GENES CREG |
| 2 | 0.0000177068 | ENDOGLIN//CD105//TRC105 |
| 3 | 0.0000156949 | ALK5 INHIBITOR//CELL BASED LUCIFERASE REPORTER ASSAY//TGFB1 |
| 4 | 0.0000133813 | LOCAL DRUG DELIVERY//HIRULOG LIKE PEPTIDE//ANGIOPEPTIN |
| 5 | 0.0000128617 | TGF BETA RECEPTORS//TGF BETA RECEPTOR//MED MED CELL BIOL |
| 6 | 0.0000118653 | LTBP//ALPHA V BETA 6//INTEGRIN ALPHAVBETA6 |
| 7 | 0.0000111910 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
| 8 | 0.0000106326 | TRANILAST//CORONARY ARTERY ENDOTHELIAL CELL//HUMAN TENONS CAPSULE FIBROBLAST |
| 9 | 0.0000105257 | SMOOTHELIN//SMTNL1//SMEMB |
| 10 | 0.0000100041 | SMAD//SMAD4//SNON |